Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586788 · ClinicalTrials.gov registry record · NA
Validation of Indiana's Early Evaluation Hub System
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT06586788: Completed NA study, sponsored by Indiana University.
NCT06586788 is a NA study that has completed, run by Indiana University. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06586788, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
The investigators' objective is to test an innovative method of autism diagnosis that integrates clinical evaluation and assessment of biobehavioral markers in a large high-risk community-referral sample of children in the primary care setting.
Primary Outcome
Sensitivity and specificity of a composite eye-tracking (i.e., index) test, which was a consolidated measure based on significant eye-tracking indices, compared to reference standard expert clinical autism diagnosis.
Interventions
- DIAGNOSTIC_TEST Eyelink Portable Duo
- DIAGNOSTIC_TEST Integrated PCP Diagnosis and Eye-tracking Biomarker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2022-09-23 |
| Phase | NA |
What the finished NCT06586788 record still lists
NCT06586788 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Eyelink Portable Duo is the first listed.
NCT06586788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06586788 about?
NCT06586788 is a clinical study titled "Validation of Indiana's Early Evaluation Hub System". The investigators' objective is to test an innovative method of autism diagnosis that integrates clinical evaluation and assessment of biobehavioral markers in a large high-risk community-referral sample of children in the primary care setting.
What is the current status of trial NCT06586788?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2019-06-07. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT06586788?
The interventions under investigation include: Eyelink Portable Duo (DIAGNOSTIC_TEST), Integrated PCP Diagnosis and Eye-tracking Biomarker (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06586788?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06586788's enrollment target sits among peer trials
154 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI